Dr. Inga Hofman Zhang from the University of Wisconsin School of Medicine provides an update on treating MDS in children. Dr. Naval Daver from MD Anderson Cancer Center talks about the relationship ...
The Myelodysplastic Syndromes (MDS) Foundation supports the positive opinion from the European Union's Committee for Medicinal Products for Human Use (CHMP) recommending approval of VIDAZA ...
SAN DIEGO, Dec. 13, 2023 /PRNewswire/ -- Notable Labs, Ltd. ("Notable") (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, ...
FOSTER CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, announced a ...
SAN DIEGO, Dec. 11, 2023 /PRNewswire/ -- Notable Labs, ("Notable") (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today ...
Tracey Iraca, MDS advocate and Executive Director of the MDS Foundation, discusses the effect of fatigue and how to manage it. Myelodysplastic syndromes (MDS) are a group of conditions in which blood ...
Practical perspectives on how to communicate MDS subclassifications with affected patients and caregivers. Bruce Feinberg, DO: Tracey, at the patient level, when you’re dealing with the health ...
MDS occur mainly, but not exclusively, in patients with a median age of about 70 years, and the crude incidence is 4 to 5 cases per 100,000 persons per year. 8 The true incidence is likely to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results